Management of Crohn's Disease of the Ileoanal Pouch With Infliximab

American Journal of Gastroenterology

Volumn 98, Issue 10, 2003, Pages 2239-2244

  Colombel, Jean Frederic ^a   Ricart, Elena ^a   Loftus Jr , Edward V ^a   Tremaine, William J ^a   Young Fadok, Tonia ^a   Dozois, Eric J ^a   Wolff, Bruce G ^a   Devine, Richard ^a   Pemberton, John H ^a   Sandborn, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ADULT; ANASTOMOSIS; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFECT; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; ILEOSTOMY; ILEUM POUCH; INTESTINE FUNCTION; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0142183673     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07675.x     Document Type: Review

References (14)

1. Deutsch AA, McLeod RS, Cullen J, et al. Results of the pelvic-pouch procedure in patients with Crohn's disease. Dis Colon Rectum 1991;34:475-7.
2. Hyman NH, Fazio VW, Tuckson WB, et al. Consequences of ileal pouch-anal anastomosis for Crohn's colitis. Dis Colon Rectum 1991;34:653-7.
3. Grobler SP, Hosie KB, Affie E, et al. Outcome of restorative proctocolectomy when the diagnosis is suggestive of Crohn's disease. Gut 1993;34:1384-8.
4. Sagar PM, Dozois RR, Wolff BG. Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 1996;39:893-8.
5. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-7.
6. Ricart E, Panaccione R, Loftus EV, et al. Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology 1999;117:429-32.
7. Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, ed. Inflammatory bowel disease. Philadelphia: WB Saunders, 2000:736-47.
8. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
9. Sandborn WJ, Hanauer S. Infliximab in the treatment of Crohn's disease: A user's guide for clinicians. Am J Gastroenterol 2002;97:2962-72.
10. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 2002;359:1541-9.
11. Sands B, Van Deventer S, Bernstein C, et al. Long-term treament of fistulizing Crohn's disease: Response to infliximab in the ACCENT II trial through 54 weeks. Gastroenterology 2002;122:A81.
12. Parsi MA, Achkar JP, Richardson S, et al. Predictors of response to Infliximab in patients with Crohn's disease. Gastroenterology 2002;123:707-13.
13. Colombel JF, Loftus EV, Tremaine WJ, et al. The safety profile of infliximab in clinical practice in patients with Crohn's disease: The Mayo Clinic experience in 500 patients. Gastroenterology 2003;124.
14. Regimbeau JM, Panis Y, Pocard M, et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum 2001;44:769-78.